Antirheumatic Therapy : Actions And Outcomes
Day, Richard O. (EDT); Furst, Daniel E. (EDT); Riel, Piet L. C. M. Van (EDT); Bresnihan, Barry (EDT)
ISBN 10: 3764365951 ISBN 13: 9783764365950
Edité par Birkhäuser, 2004
Neuf(s)
Couverture rigide
Vendeur
GreatBookPrices, Columbia, MD, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Vendeur AbeBooks depuis 6 avril 2009
Cet article spécifique n'est plus disponible.
A propos de cet article
Description :
N° de réf. du vendeur 3195427-n
Synopsis :
This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Détails bibliographiques
Titre : Antirheumatic Therapy : Actions And Outcomes
Éditeur : Birkhäuser
Date d'édition : 2004
Reliure : Couverture rigide
Etat : New
Meilleurs résultats de recherche sur AbeBooks
Image d'archives
Antirheumatic Therapy : Actions and Outcomes; (Progress in Inflammation Research Series)
Edité par
Birkhauser, Switzerland, 2005
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Ancien ou d'occasion
Couverture rigide
Vendeur : The Book Exchange, Macclesfield, CHESH, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Near Fine. No Jacket. 3764365951. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 344 pages, index, refs, illustrated with charts, photos and diagrams. A comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented. Contents clean, tight and bright. Book. N° de réf. du vendeur 028680
Quantité disponible : 1 disponible(s)
Image d'archives
Antirheumatic Therapy: Actions and Outcomes.
Edité par
Basel, Birkhäuser., 2005
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Ancien ou d'occasion
Couverture rigide
Vendeur : Universitätsbuchhandlung Herta Hold GmbH, Berlin, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
XII, 343 p. Hardcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Progress in Inflammation Research. Sprache: Englisch. N° de réf. du vendeur 320FB
Quantité disponible : 2 disponible(s)
Image d'archives
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Edité par
Birkh, 2005
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Ancien ou d'occasion
Couverture rigide
Vendeur : Lexington Books Inc, Idaho Falls, ID, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Good. Good+; Contents are tight and clean; Ex-Library; Hard Cover; Birkhauser; 2005; 0. N° de réf. du vendeur 80017
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Anti-Inflammatory or Anti-Rheumatic Drugs
Edité par
Birkhäuser Basel, 2004
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Neuf
Couverture rigide
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive and well structured according to classes of agentsIncludes an outlook on future molecular targetsInternational authorshipOur goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the inc. N° de réf. du vendeur 5279460
Quantité disponible : Plus de 20 disponibles
Antirheumatic Therapy: Actions and Outcomes
impression à la demandeVendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Antirheumatic Therapy: Actions and Outcomes | Richard O. Day (u. a.) | Buch | xiii | Englisch | 2004 | Springer Basel | EAN 9783764365950 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. N° de réf. du vendeur 102445756
Quantité disponible : 5 disponible(s)
Image fournie par le vendeur
Antirheumatic Therapy: Actions and Outcomes
Edité par
Birkhäuser Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Neuf
Couverture rigide
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 364 pp. Englisch. N° de réf. du vendeur 9783764365950
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Antirheumatic Therapy: Actions and Outcomes
Edité par
Birkhäuser Basel, 2004
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Neuf
Couverture rigide
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. N° de réf. du vendeur 9783764365950
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Anti-Inflammatory or Anti-Rheumatic Drugs
Edité par
Springer, Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Neuf
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. 343 pp. Englisch. N° de réf. du vendeur 9783764365950
Quantité disponible : 2 disponible(s)
Image d'archives
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9783764365950_new
Quantité disponible : Plus de 20 disponibles
Image d'archives
Antirheumatic Therapy: Actions and Outcomes (Hardcover)
Edité par
Birkhauser Verlag AG, Basel, 2004
ISBN 10 : 3764365951
ISBN 13 : 9783764365950
Neuf
Couverture rigide
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : new. Hardcover. This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients quality of life and long-term outcomes are presented. Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9783764365950
Quantité disponible : 1 disponible(s)